Last mentioned: Feb 21, 2026
A trio of high-growth companies across genomics, biotechnology, and digital logistics are set to report quarterly results this Monday. Investors will be closely monitoring GeneDx's path to profitability, PepGen's clinical cash runway, and Freightos's transaction volume growth.
GeneDx (WGS) and PepGen (PEPG) are scheduled to release financial results on Monday, marking a pivotal moment for the clinical genomics and neuromuscular therapeutic sectors. Investors are looking for GeneDx to demonstrate a sustainable path to profitability through its whole genome sequencing volume, while PepGen's update will focus on its clinical pipeline and cash position.
GeneDx and PepGen are scheduled to report quarterly financial results on Monday, marking a pivotal moment for the genomic diagnostics and neuromuscular biotech sectors. Investors are looking for GeneDx's continued path toward profitability through whole genome sequencing and PepGen's clinical pipeline progress.
Freightos (CRGO) is set to report earnings this Monday, offering a critical window into the health of digital freight booking and global shipping rate transparency. As the industry grapples with post-pandemic normalization and geopolitical disruptions, the company's transaction volumes will serve as a bellwether for the logistics technology sector.